NRG1 and amyotrophic lateral sclerosis: A genetically well-defined alternative approach for investigating the impact of augmenting NRG1 signalling on ALS-relevant pathology in the SOD1G93A model is the use of transgenic mouse lines with thymocyte differentiation antigen 1.2 promoter-driven neuronal overexpression of distinct NRG1 isoforms.